Literature DB >> 27533286

Correlation Between Hip Arthroscopy Outcomes and Preoperative Anesthetic Hip Joint Injections, MR Arthrogram Imaging Findings, and Patient Demographic Characteristics.

Lauren M Ladd1, James S Keene2, Alejandro Munoz Del Rio3,4, Humberto G Rosas3.   

Abstract

OBJECTIVE: The purpose of this study is to determine whether the preoperative response to intraarticular hip anesthetic injection correlates with the outcome of hip arthroscopy. A secondary aim is to determine whether the outcome of arthroscopy correlates with intraarticular pathologic findings or patient demographic characteristics.
MATERIALS AND METHODS: Ninety-three patients who underwent MR arthrography (MRA), preoperative injections of anesthetic into the hip joint (with pain scores documented), and subsequent hip arthroscopy (with a modified Harris Hip Score [mHHS] determined at 1 year after arthroscopy) were included in the study. MRA images and surgery reports were retrospectively reviewed to identify information about labral tear type and size and cartilage damage grade. The correlation between the response to hip anesthetic injection (defined as poor [0-30% improvement], moderate [31-60% improvement], or good [61-100% improvement]) and the surgical outcome (poor, fair, or good, as determined on the basis of the mHHS or the need for repeat surgery) was evaluated using the Fisher exact test. Univariate analysis (performed using the Fisher exact test) and multivariate analysis (performed using ANOVA) of correlations with age, sex, body mass index (BMI [weight in kilograms divided by the square of height in meters]), the interval between injection and surgery, labral tear type and size, and cartilage damage grade were also performed.
RESULTS: Comparison of the response to preoperative hip anesthetic injection with the outcome of arthroscopy at 1 year indicated no statistically significant association (p = 0.59). The BMI of the patient, however, was statistically significantly associated with surgical outcome (p = 0.03), with a BMI of less than 25 denoting a higher likelihood of a good surgical outcome. No statistically significant correlations were noted in analyses of surgical outcomes and patient age (p = 0.31) and sex (p = 0.83); the interval between injection and surgery (p = 0.28); labral tear type, as determined by MRA (p = 0.34) and arthroscopy (p = 0.47); labral tear size, as determined by MRA (p = 0.34); and cartilage grade, as determined by MRA (p = 0.58) and arthroscopy (p = 0.26).
CONCLUSION: No positive or negative correlation was noted between the response to preoperative hip anesthetic injection and the outcome at 1 year after hip arthroscopy. Only BMI was shown to correlate with the surgical outcome.

Entities:  

Keywords:  MR arthrography; anesthetic joint injection; arthroscopy; hip; surgical outcome

Mesh:

Substances:

Year:  2016        PMID: 27533286     DOI: 10.2214/AJR.16.16383

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

1.  Value of response to anesthetic injection during hip MR arthrography to differentiate between intra- and extra-articular pathology.

Authors:  Arvin B Kheterpal; Katherine M Bunnell; Jad S Husseini; Connie Y Chang; Scott D Martin; Adam C Zoga; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2019-10-23       Impact factor: 2.199

2.  Prediction of intra-articular pathology and arthroscopic outcomes for femoroacetabular impingement and labral tear based on the response to preoperative anaesthetic hip joint injections.

Authors:  Nobuaki Chinzei; Shingo Hashimoto; Shinya Hayashi; Koji Takayama; Tomoyuki Matsumoto; Ryosuke Kuroda
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-01-20

3.  Diagnostic intra-articular injection with provocative functional testing predicts patient-reported outcomes following hip arthroscopy: a prospective investigation.

Authors:  Brittany E Haws; Chad G Condidorio; Kelly L Adler; Brian D Giordano
Journal:  J Hip Preserv Surg       Date:  2022-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.